Global Active Pharmaceutical Ingredients Market 2018-2024
23-Jun-2018 | Number of pages: 220 | Report Id: BMRC PH 130 | Report Format: | Status: Published

Global Active Pharmaceutical Ingredients Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Brandessence Market Research is working on a new report titleGlobal Active Pharmaceutical Ingredients Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″. Rising geriatric population with increase in prevalence of chronic diseases such as cancer, neurological diseases, cardiovascular diseases and lifestyle related disorders such as Hypertension, Obesity and Metabolic Syndromes are likely to enhance the growth of Global Active Pharmaceutical Ingredients Market.

Scope of Global Active Pharmaceutical Ingredients Market Reports – 

Any drug is consisting of two ingredients, the first one is the Active Pharmaceutical Ingredient (API) which is the dominant ingredient of the drug and the second is an excipients. Active Pharmaceutical Ingredients (API) is used in the manufacturing of various pharmaceutical formulations such as Syrups, Tablets, Creams and Capsules. Active Pharmaceutical Ingredients (API) is chemically as well as biologically active element of drugs which provides health benefits and used to cure, mitigation, treatment and prevention of diseases. The global API market has viewed incredible growth over the last few decades due to the augmented use of drugs and biologics in the treatment of diseases. The growing acceptance of quality standards in API manufacturing such as Good Manufacturing Practices (GMP), current GMP (CGMP) and the global adoption of International Conference on Harmonization (ICH) guidelines has facilitated to improve the safety standards. API can be obtain by synthetic process or from natural sources. APIs can’t used in the raw form because it is obtain from crude form of drug which will not have proper pharmacodynamics and pharmacokinetics parameters.  So APIs are combined with the suitable excipients which are pharmacologically and therapeutically inert but improve its stability and activities.

Contents in drugs is not fixed it may contain one or more API and according to the dosage or prescription it will vary from individual to individual. Certain drugs such as combination therapies have numerous active ingredients, which treat different symptoms or act in different ways.

Global Active Pharmaceutical Ingredients Market has been divides on the basis of Drug Type, API Type, Type of Manufacturer, Therapeutic Area and Geography. On the basis of Drug Type of Global Active Pharmaceutical Ingredients Market is classified into Branded Prescription Drugs, Generic Prescription Drugs, OTC, Prescription Drugs and Other. On the basis of API Type of Global Active Pharmaceutical Ingredients Market is classified into Synthetic API, Biotech API and Other. On the basis of Type of Manufacturer Global Active Pharmaceutical Ingredients Market is classified into Captive Manufacturing or In-house, Merchant or Outsourced APIs and Other. On the basis of Therapeutic Area of Global Active Pharmaceutical Ingredients Market is classified into Cardiovascular Disorders, Neurological Disorders, Oncology, Diabetes, Musculoskeletal Disorders, Endocrinology, NSAIDs, Orthopedics, Urology, Nephrology, Ophthalmology, Pulmonology, Women’s Health, Gastroenterology and Others.

The regions covered in Global Active Pharmaceutical Ingredients Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Active Pharmaceutical Ingredients Market Reports –

Global Oncology Nutrition Market reports cover prominent players Aurobindo Pharma, BASF, Boehringer Ingelheim, Cipla, Dr. Reddy’s Laboratories, Lonza Group, Teva Pharmaceutical Industries, Abbott Laboratories, Actavis, Aesica, Albemarle, AMPAC Fine Chemicals, Anhui Biochem United Pharmaceutical, Anuh Pharma, Aptuit, AstraZeneca, Biocon, Bristol-Myers Squibb, Calyx Chemicals & Pharmaceuticals, Cambrex, Cilag, Elanco Animal Health, CIRON Drugs and Pharmaceuticals, CTX Life Sciences, Dishman Pharmaceuticals & Chemicals, Dr. Paul Lohmann, Emcure Pharmaceuticals, Farmabios, F. Hoffmann-La Roche, GlaxoSmithKline, Guilin Pharmaceutical, Hetero Drugs, Hospira, Ipca Laboratories, Janssen Pharmaceutica, Johnson Matthey, Laurus Labs, Lupin, Mallinckrodt Pharmaceuticals, Mangalam Drugs & Organics, Merck, Mylan, Novartis, Novasep, Pen Tsao Chemical Industry, Pfizer, Ranbaxy Laboratories, Royal DSM, Sanofi-Aventis, Sequent Scientific, Shanghai Desano Chemical Pharmaceutical, Shasun, Ceva Animal Health Inc., Shijiazhuang Lonzeal Pharmaceuticals, Sigma-Aldrich, STP Sun Pharmaceutical Industries, WuXi AppTec, Zhejiang Langhua Pharmaceuticals and Zhuhai Rundu Pharmaceuticalharm.

Global Active Pharmaceutical Ingredients Market Dynamics –

Rise in Outsourcing Activities, Increasing in healthcare expenditure, Improvements in the technology of API manufacturing, Growing Importance of Generics and rise in Abbreviated New Drug Applications (ANDA) will drive the Global Active Pharmaceutical Ingredients Market. Other factors playing a vital role for the growth of Global Active Pharmaceutical Ingredients Market include the increase in the geriatric population. A greater generic acceptance level in developed countries from 28% to 33% is boosting global medicine expenditure. Moreover growth in chronic & lifestyles related disorders and increasing acceptance for targeted therapy approach in cancer treatment, aiding greater access to improved, lifesaving healthcare services.

Furthermore, increasing promotion of generic drugs by the government is also fueling the growth of the active pharmaceutical ingredients market. Decrease in R&D Spending, production cost and variable drug price control policies hinder the growth of Global Active Pharmaceutical Ingredients Market.

An intense focus on commercializing drugs and reducing operating costs by outsourcing R&D activities can improve the organizational efficiency significantly. Outsourcing at later stages of expansion through the appointment of strategic partners can potentially improve operational efficiencies throughout the value chain. A balanced portfolio approach goes a long way in expanding sales and simultaneously reducing risk. This could be by possessing branded generic drugs, branded drugs, and unbranded drugs within the same portfolio. Adding to that, well defined forward linkages in the supply chain can save larger market share in diverse regions over the forecast period. Stringent regulatory requirements and absence of awareness in majority of people might restrain the growth of the Global Active Pharmaceutical Ingredients Market.

Global Active Pharmaceutical Ingredients Market Regional Analysis –

From a geographical standpoint, North America commanded a major share of the Global Active Pharmaceutical Ingredients Market due to the rise in research and development programs in the field of drugs and medical science and it is likely to stay on its place in the future, owing to rising favorable government initiatives for usage of generic drugs and technological advancements in the field of drug. Europe accounts second largest market which is followed by Asia Pacific. However, Asia Pacific is expected to witness the highest growth during the forecast period owing to the availability of affordable labor. Therefore major companies in the industry are located the API manufacturing plants in the developing countries such as China and India. The significant growth of the Asia Pacific market is mainly attributed to increasing healthcare expenditure, increased awareness and accessibility, increasing number of preterm births, rising geriatric population and large pool of generic medicine producers in the region. Advanced healthcare facilities, rapid improvements in the health insurance sector and increasing healthcare expenditure.

Key Benefits for Global Active Pharmaceutical Ingredients Market Reports –

  • Global Active Pharmaceutical Ingredients Market report covers in depth historical and forecast analysis.
  • Global Active Pharmaceutical Ingredients Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Active Pharmaceutical Ingredients Market report helps to identify opportunities in market place.
  • Global Active Pharmaceutical Ingredients Market report covers extensive analysis of emerging trends and competitive landscape.

Global Active Pharmaceutical Ingredients Market Segmentation

 Global Active Pharmaceutical Ingredients Market: By Drug Type Analysis

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Prescription Drugs
  • Other

Global Active Pharmaceutical Ingredients Market: By API Type Analysis

  • Synthetic API
  • Synthetic APIs Market, by Type
  • Innovative Synthetic APIs
  • Generic Synthetic APIs
  • Biotech API
  • Biotech APIs Market, by Type
  • Innovative Biotech APIs
  • Biosimilars
  • Biotech APIs Market, by Product
  • Monoclonal Antibodies
  • Hormones
  • Cytokines
  • Fusion Proteins
  • Therapeutic Enzymes
  • Vaccines
  • Blood Factors
  • Biotech APIs Market, by Product
  • Mammalian Expression Systems
  • Microbial Expression Systems
  • Yeast Expression Systems
  • Insect Expression Systems
  • Plant Expression Systems
  • Other Expression Systems
  • Other

Global Active Pharmaceutical Ingredients Market: By Type of Manufacturer Analysis

  • Captive Manufacturing or In-house
  • Merchant or Outsourced APIs
  • Other

Global Active Pharmaceutical Ingredients Market: By Therapeutic Area Analysis

  • Cardiovascular Disorders
  • Neurological Disorders
  • Oncology
  • Diabetes
  • Musculoskeletal Disorders
  • Endocrinology
  • NSAIDs
  • Orthopaedics
  • Urology
  • Nephrology
  • Ophthalmology
  • Pulmonology
  • Women’s Health
  • Gastroenterology
  • Other

Global Active Pharmaceutical Ingredients Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Active Pharmaceutical Ingredients Market 2018-2024

Our 220 pages report provides 62 tables, 84 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Active Pharmaceutical Ingredients Market
  • To receive forecasts of Global Active Pharmaceutical Ingredients Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions 
  • To discover the views of experts in the Global Active Pharmaceutical Ingredients Market sector
  • To determine the forces and factor that influences the market for Global Active Pharmaceutical Ingredients Market: drivers, restraints, opportunities and threats
  • To find out where the Global Active Pharmaceutical Ingredients Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Active Pharmaceutical Ingredients Market: By Region Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

GlobalXXXXXXXXXX
North AmericaXXXXXXXXXX
EuropeXXXXXXXXXX
Asia PacificXXXXXXXXXX
Latin AmericaXXXXXXXXXX
Middle East & AfricaXXXXXXXXXX
GlobalXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Active Pharmaceutical Ingredients Market: By Drug Type Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Branded Prescription DrugsXXXXXXXXXX
Generic Prescription DrugsXXXXXXXXXX
OTC Prescription Drugs XXXXXXXXXX
OtherXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Active Pharmaceutical Ingredients Market: By API Type Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Synthetic Chemical APIXXXXXXXXXX
Biotech APIXXXXXXXXXX
OthersXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Active Pharmaceutical Ingredients Market: By Type of Manufacturer Analysis

 

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Captive Manufacturing or In-houseXXXXXXXXXX
Merchant or Outsourced APIs XXXXXXXXXX
OtherXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Active Pharmaceutical Ingredients Market: By Type of Manufacturer Analysis

 

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Cardiovascular DisordersXXXXXXXXXX
Neurological DisordersXXXXXXXXXX
OncologyXXXXXXXXXX
DiabetesXXXXXXXXXX
Musculoskeletal DisordersXXXXXXXXXX
EndocrinologyXXXXXXXXXX
NSAIDsXXXXXXXXXX
OrthopaedicsXXXXXXXXXX
UrologyXXXXXXXXXX
NephrologyXXXXXXXXXX
OphthalmologyXXXXXXXXXX
PulmonologyXXXXXXXXXX
Women’s HealthXXXXXXXXXX
Gastroenterology XXXXXXXXXX
OtherXXXXXXXXXX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey of Global Active Pharmaceutical Ingredients Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

 

Companies Mentioned in This Report,

  • Aurobindo Pharma
  • BASF
  • Boehringer Ingelheim
  • Cipla
  • Reddy’s Laboratories
  • Lonza Group
  • Teva Pharmaceutical Industries
  • Abbott Laboratories
  • Actavis
  • Aesica
  • Albemarle
  • AMPAC Fine Chemicals
  • Anhui Biochem United Pharmaceutical
  • Anuh Pharma
  • Aptuit
  • AstraZeneca
  • Biocon
  • Bristol-Myers Squibb
  • Calyx Chemicals & Pharmaceuticals
  • Cambrex
  • Cilag
  • Elanco Animal Health
  • CIRON Drugs and Pharmaceuticals
  • CTX Life Sciences
  • Dishman Pharmaceuticals & Chemicals
  • Paul Lohmann
  • Emcure Pharmaceuticals
  • Farmabios
  • Hoffmann-La Roche
  • GlaxoSmithKline
  • Guilin Pharmaceutical
  • Hetero Drugs
  • Hospira
  • Ipca Laboratories
  • Janssen Pharmaceutica
  • Johnson Matthey
  • Laurus Labs
  • Lupin
  • Mallinckrodt Pharmaceuticals
  • Mangalam Drugs & Organics
  • Merck
  • Mylan
  • Novartis
  • Novasep
  • Pen Tsao Chemical Industry
  • Pfizer
  • Ranbaxy Laboratories
  • Royal DSM
  • Sanofi-Aventis
  • Sequent Scientific
  • Shanghai Desano Chemical Pharmaceutical
  • Shasun
  • Ceva Animal Health Inc.
  • Shijiazhuang Lonzeal Pharmaceuticals
  • Sigma-Aldrich
  • STP Sun Pharmaceutical Industries
  • WuXi AppTec
  • Zhejiang Langhua Pharmaceuticals
  • Zhuhai Rundu Pharmaceuticalharm
  • Others

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Active Pharmaceutical Ingredients Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Active Pharmaceutical Ingredients Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Active Pharmaceutical Ingredients Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  3. Chapter – Global Active Pharmaceutical Ingredients Market Overview: Quantitative Analysis
    • Global Active Pharmaceutical Ingredients Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Active Pharmaceutical Ingredients Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Active Pharmaceutical Ingredients Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  4. Chapter – 3.2. Global Oncology Nutrition Market: by type of Cancer
  • Global Active Pharmaceutical Ingredients Market(USD Million), by Manufacturer, 2014 – 2024
  • Global Active Pharmaceutical Ingredients Market Production (K Unit), by Manufacturer, 2014 – 2024
  • Global Active Pharmaceutical Ingredients Market Consumption (K Unit), Manufacturer, 2014 – 2024
  • Global Active Pharmaceutical Ingredients Market Share (%), by Manufacturer, 2017
  • Global Active Pharmaceutical Ingredients Market Price (USD/Unit), by Manufacturer, 2014 – 2024
  • Global Active Pharmaceutical Ingredients Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
  • Merger & Acquisition
  • Collaborations and Partnership
  • New Product Launch
  1. Chapter – Global Oncology Nutrition Market: Regional Analysis
    • North America
    • North America Global Active Pharmaceutical Ingredients Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Active Pharmaceutical Ingredients Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Active Pharmaceutical Ingredients Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Active Pharmaceutical Ingredients Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Active Pharmaceutical Ingredients Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Active Pharmaceutical Ingredients Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  2. Chapter – Company Profiles
    • Aurobindo Pharma
    • Overview
    • Financials
  • Product portfolio
  • Global Active Pharmaceutical Ingredients Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
  • Global Active Pharmaceutical Ingredients Market Share (%), 2014 – 2017
    • BASF
    • Boehringer Ingelheim
    • Cipla
    • Reddy’s Laboratories
    • Lonza Group
    • Teva Pharmaceutical Industries
    • Abbott Laboratories
    • Actavis
    • Aesica
    • Albemarle
    • AMPAC Fine Chemicals
    • Anhui Biochem United Pharmaceutical
    • Anuh Pharma
    • Aptuit
    • AstraZeneca
    • Biocon
    • Bristol-Myers Squibb
    • Calyx Chemicals & Pharmaceuticals
    • Cambrex
    • Cilag
    • Elanco Animal Health
    • CIRON Drugs and Pharmaceuticals
    • CTX Life Sciences
    • Dishman Pharmaceuticals & Chemicals
    • Paul Lohmann
    • Emcure Pharmaceuticals
    • Farmabios
    • Hoffmann-La Roche
    • GlaxoSmithKline
    • Guilin Pharmaceutical
    • Hetero Drugs
    • Hospira
    • Ipca Laboratories
    • Janssen Pharmaceutica
    • Johnson Matthey
    • Laurus Labs
    • Lupin
    • Mallinckrodt Pharmaceuticals
    • Mangalam Drugs & Organics
    • Merck
    • Mylan
    • Novartis
    • Novasep
    • Pen Tsao Chemical Industry
    • Pfizer
    • Ranbaxy Laboratories
    • Royal DSM
    • Sanofi-Aventis
    • Sequent Scientific
    • Shanghai Desano Chemical Pharmaceutical
    • Shasun
    • Ceva Animal Health Inc.
    • Shijiazhuang Lonzeal Pharmaceuticals
    • Sigma-Aldrich
    • STP Sun Pharmaceutical Industries
    • WuXi AppTec
    • Zhejiang Langhua Pharmaceuticals
    • Zhuhai Rundu Pharmaceuticalharm
    • Other
  1. Chapter – Market Research and Findings

  • Aurobindo Pharma
  • BASF
  • Boehringer Ingelheim
  • Cipla
  • Reddy’s Laboratories
  • Lonza Group
  • Teva Pharmaceutical Industries
  • Abbott Laboratories
  • Actavis
  • Aesica
  • Albemarle
  • AMPAC Fine Chemicals
  • Anhui Biochem United Pharmaceutical
  • Anuh Pharma
  • Aptuit
  • AstraZeneca
  • Biocon
  • Bristol-Myers Squibb
  • Calyx Chemicals & Pharmaceuticals
  • Cambrex
  • Cilag
  • Elanco Animal Health
  • CIRON Drugs and Pharmaceuticals
  • CTX Life Sciences
  • Dishman Pharmaceuticals & Chemicals
  • Paul Lohmann
  • Emcure Pharmaceuticals
  • Farmabios
  • Hoffmann-La Roche
  • GlaxoSmithKline
  • Guilin Pharmaceutical
  • Hetero Drugs
  • Hospira
  • Ipca Laboratories
  • Janssen Pharmaceutica
  • Johnson Matthey
  • Laurus Labs
  • Lupin
  • Mallinckrodt Pharmaceuticals
  • Mangalam Drugs & Organics
  • Merck
  • Mylan
  • Novartis
  • Novasep
  • Pen Tsao Chemical Industry
  • Pfizer
  • Ranbaxy Laboratories
  • Royal DSM
  • Sanofi-Aventis
  • Sequent Scientific
  • Shanghai Desano Chemical Pharmaceutical
  • Shasun
  • Ceva Animal Health Inc.
  • Shijiazhuang Lonzeal Pharmaceuticals
  • Sigma-Aldrich
  • STP Sun Pharmaceutical Industries
  • WuXi AppTec
  • Zhejiang Langhua Pharmaceuticals
  • Zhuhai Rundu Pharmaceuticalharm
  • Others